Hôpital Raymond Poincaré
Service de Médecine Physique et Réadaptation
104 Bd Raymond Poincaré
Tel: 01 47 10 70 60
Djamel Bensmail is professor of physical and rehabilitation medicine at the university of Versailles Saint Quentin since 2010 and head of the spinal cord injury-multiple sclerosis unit and spasticity management unit of the R. Poincaré hospital. He is director of the Master degree Neurological Handicap from Paris Saclay university. He is president of the Garches Foundation dedicated to neurological handicap (research, education and patient management). He is coordinator of a MS care resource and referral center in the western part of Paris area. He is member of the team 3 of the U1179 (ENDICAP) Inserm-UVSQ laboratory. He is also a board member of the French society of physical medicine and rehabilitation (SOFMER). He published 99 peer-reviewed original publications.
Some publications from the last years:
Bernuz B, Genet F, Terrat P, Pradon D, Barbot F, Bussel B, Bensmail D. Botulinum toxin effect on voluntary and stretch reflex-related torque produced by the quadriceps: an isokinetic pilot study. Neurorehabil Neural Repair. 2012 Jun;26(5):542-7. Hameau S, Zory R, Latrille C, Roche N, Bensmail D. Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis. Eur J Phys Rehabil Med. 2016 May 10.
Hameau S, Bensmail D, Roche N, Zory R. Fatigability in patients with multiple sclerosis during maximal concentric contractions. Arch Phys Med Rehabil. 2017 Jan 24. pii: S0003-9993(17)30024-2.
Levy J, Bensmail D, Brotier-Chomienne A, Butel S, Joussain C, Hugeron C, Prigent H. Respiratory impairment in multiple sclerosis: a study of respiratory function in wheelchair-bound patients. Eur J Neurol. 2017 Jan 3. doi:10.1111/ene.13231.
Wissel J, Bensmail D, Ferreira JJ, Molteni F, Satkunam L, Moraleda S, Rekand T, McGuire J, Scheschonka A, Flatau-Baqué B, Simon O, Rochford ET, Dressler D,Simpson DM; TOWER study investigators. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study. Neurology. 2017 Mar 10.
Levy J, Hartley S, Mauruc-Soubirac E, Leotard A, Lofaso F, Quera-Salva MA, Bensmail D. Spasticity or periodic limb movements? Eur J Phys Rehabil Med. 2017 Dec 4. doi: 10.23736/S1973-9087.17.04886-9.
Levy J, Molteni F, Cannaviello G, Lansaman T, Roche N, Bensmail D. Does botulinum toxin treatment improve upper limb active function? Ann Phys Rehabil Med. 2018 Jun 27. pii: S1877-0657(18)31409-X. doi: 10.1016/j.rehab.2018.05.1320.
Supiot A, Geiger M, Bensmail D, Aegerter P, Pradon D, Roche N. Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX). BMC Neurol. 2018 Aug 2;18(1):104. doi: 10.1186/s12883-018-1110-8.
Khan F, Amatya B, Bensmail D, Yelnik A. Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews. Ann Phys Rehabil Med. 2017 Oct 16. pii: S1877-0657(17)30415-3.